Signals, Powered By EquityPandit
Marksans Pharma has received the US health regulator‘s approval for loratadine liquid filled capsules that are used in treating allergies, in the American market.
Marksans Pharma has said in a BSE filing that ” USFDA has granted approval for an abbreviated new drug application (ANDA) for loratadine liquid filled capsules 10 mg.”
The Loratadine liquid-filled capsules are therapeutically equivalent to the reference listed drug Claritin Liqui-Gels Capsules 10 mg of Bayer Healthcare LLC.
